Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2

NARecruitingINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

June 6, 2023

Primary Completion Date

May 2, 2025

Study Completion Date

December 31, 2025

Conditions
Long COVIDInsulin ResistanceInsulin Sensitivity
Interventions
PROCEDURE

Adipose Tissue Biopsy

After an overnight fast, approximately 1-2 grams of subcutaneous fat will be removed by a needle. Participants will have a local anesthetic prior to the procedure. The needle fat biopsy will be repeated at quarterly intervals for one year (every 3 months). We will also draw 1 10mL tube of blood at each biopsy for measurement of inflammatory cytokines.

DIAGNOSTIC_TEST

Steady State Plasma Glucose (SSPG) Test

An Insulin Sensitivity Test (SSPG: Steady State Plasma Glucose) is performed to determine if participants are insulin sensitive or insulin resistant. This test is approximately 5-6 hours in length. Participants will be asked to fast for 12 hours. The insulin sensitivity test is designed to measure how well your cells remove glucose from your blood in response to insulin. During this test participants will have two small catheters (tubing) placed in their veins (I.V. lines). The total amount of blood that will be drawn during this test will be 140 mL of blood (approximately 9.5 tablespoons). Insulin is a natural hormone, and octreotide (a synthetic hormone) is a drug that temporarily blocks the secretion of insulin from your pancreas. A member of the research team is present and monitoring the results along with the nursing staff.

Trial Locations (2)

94304

ENROLLING_BY_INVITATION

Clinical and Translational Research Unit, Palo Alto

94305

RECRUITING

Stanford Health, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER